Emmaus Life Sciences, Inc.
small molecule therapeutics for rare and orphan diseases
- Sector
- Biotech
- Headquarters
- TORRANCE, CA
- Latest Form D
- $235K offered, Jan 2023
- Total capital
- $13.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $13.1M
- 23 Form D · last Jan 2023
- 45 months since last filing
- Federal contracts
- $60K
- 2 awards · Defense
- Rank in Biotech#351 of 4373
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Offering registeredForm D · SEC · 22nd filing$235K
- Offering registeredForm D · SEC · 21st filing$34M
- Private capital raisedForm D · SEC · 20th filing$110K
- Private capital raisedForm D · SEC · 19th filing$1.9M
- Offering registeredForm D · SEC · 18th filing$3.7M
- Private capital raisedForm D · SEC · 17th filing$948K
- Private capital raisedForm D · SEC · 16th filing$1.6M
- Private capital raisedForm D · SEC · 15th filing$260K
- Private capital raisedForm D · SEC · 14th filing$415K
- Private capital raisedForm D · SEC · 13th filing$222K
- Private capital raisedForm D · SEC · 12th filing$73K
- Private capital raisedForm D · SEC · 11th filing$595K
- Private capital raisedForm D · SEC · 10th filing$136K
- Private capital raisedForm D · SEC · 9th filing$300K
- Private capital raisedForm D · SEC · 8th filing$270K
- Private capital raisedForm D · SEC · 7th filing$450K
- Private capital raisedForm D · SEC · 6th filing$1.6M
- Private capital raisedForm D · SEC · 5th filing$500K
- Private capital raisedForm D · SEC · 4th filing$1M
- Private capital raisedForm D · SEC · 3rd filing$200K
- Private capital raisedForm D · SEC · 2nd filing$500K
- Private capital raisedForm D · SEC · 1st filing$2M
Show 2 earlier federal awards
- Federal contractDefense · 001 Per Unit Of The Peer Report Is$20K
- Federal contractDefense · 001 - Psychiatric Eeg Evaluation Reports$40K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Founders and team
From SEC Form D filings- Alfred E. Osborne Jr.DirectorNamed in SEC Form D filings
- Amir A. HeshmatpourDirectorNamed in SEC Form D filings
- Charles StarkExecutive OfficerNamed in SEC Form D filings
- George SekulichExecutive OfficerNamed in SEC Form D filings
- Henry A. McKinnellDirectorNamed in SEC Form D filings
- Ian Pine ZwickerDirectorNamed in SEC Form D filings
Show all 23 people
- Jane Pine WoodDirectorNamed in SEC Form D filings
- Jon T KuwaharaDirectorNamed in SEC Form D filings
- Joseph SherwoodExecutive OfficerNamed in SEC Form D filings
- Kurt KrugerExecutive OfficerNamed in SEC Form D filings
- Lan TranExecutive OfficerNamed in SEC Form D filings
- Lim SeahDirectorNamed in SEC Form D filings
- Masaharu OsatoDirectorNamed in SEC Form D filings
- Maurice J. DeWaldDirectorNamed in SEC Form D filings
- Peter T. LudlumExecutive OfficerNamed in SEC Form D filings
- Robert DickeyDirectorNamed in SEC Form D filings
- Tracey C. DoiDirectorNamed in SEC Form D filings
- Wei Peu (Derek) ZenDirectorNamed in SEC Form D filings
- Wei Peu ZenDirectorNamed in SEC Form D filings
- Wei Peu ZenDirectorNamed in SEC Form D filings
- Willis C LeeExecutive Officer, DirectorNamed in SEC Form D filings
- Yasushi T NagasakiExecutive OfficerNamed in SEC Form D filings
- Yutaka NiiharaExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 4- PendingEngineering Of Stratified Cell Sheets Using Mesenchymal Stem CellsUSPTOApplication 18703305
- PendingEngineering Of Stratified Cell Sheets Using Mesenchymal Stem CellsUSPTOApplication PCTUS2022047381
- PendingCompositions And Methods For Treating CancerUSPTOApplication 63286427
Show all 4 patent records
- Engineering Of Stratified Cell Sheets Using Mesenchymal Stem CellsDec 19, 2024 · Application 18703305Pending
- Engineering Of Stratified Cell Sheets Using Mesenchymal Stem CellsApplication PCTUS2022047381Pending
- Compositions And Methods For Treating CancerApplication 63286427Pending
- Engineering of different stratified cell sheets using human adipose stromal cellsApplication 63360710Pending
Related companies, and why
- CELLULAR RESEARCH, INC.Similar federal contract value in Biotech · $63K in contracts
- Radiant Genomics, Inc.Similar federal contract value in Biotech · $63K in contracts
- LEADSCOPE, INC.Similar federal contract value in Biotech · $62K in contracts
- Transposagen Biopharmaceuticals, Inc.Similar federal contract value in Biotech · $56K in contracts
- Mitochon Pharmaceuticals, Inc.Similar federal contract value in Biotech · $50K in contracts
- Oralome IncSimilar federal contract value in Biotech · $50K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .